First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors-Reference-Cited by-同舟云学术

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors

Published:2017-01-09 Issue:3 Volume:35 Page:315-323
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Shapiro Geoffrey I.,Vaishampayan Ulka N.,LoRusso Patricia,Barton Jeremy,Hua Steven,Reich Steven D.,Shazer Ronald,Taylor Carrie T.,Xuan Dawei,Borghaei Hossein

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/article/10.1007/s10637-016-0419-7/fulltext.html

Reference30 articles.

1. Alley SC, Okeley NM, Senter PD (2010) Antibody-drug conjugates: targeted drug delivery for cancer. Curr Opin Chem Biol 14:529–537

2. Sapra P, Hooper AT, O’Donnell CJ et al (2011) Investigational antibody drug conjugates for solid tumors. Expert Opin Investig Drugs 20:1131–1149

3. Boghaert ER, Sridharan L, Khandke KM et al (2008) The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. Int J Oncol 32:221–234

4. Hole N, Stern PL (1990) Isolation and characterization of 5T4, a tumour-associated antigen. Int J Cancer 45:179–184

5. Hole N, Stern PL (1988) A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. Br J Cancer 57:239–246

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of the antibody–drug conjugate clinical landscape;mAbs;2023-08-28

2. Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy;Clinical and Translational Oncology;2023-07-15

3. CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets;Cancers;2023-02-11

4. Drug targeting in anticancer chemotherapy;Medicinal Chemistry of Anticancer Drugs;2023

5. In vivo therapeutic effects of small molecule-drug conjugates enhanced by Fc grafting;Biomaterials;2022-11